|
|
|
 |
FDA Approval Activities for this Drug…
OXYMORPHONE HYDROCHLORIDE Injection 1.5MG/ML NUMORPHAN ENDO 011707 OXYMORPHONE HYDROCHLORIDE Injection 1MG/ML NUMORPHAN ENDO 011738 OXYMORPHONE HYDROCHLORIDE Suppository; Rectal 5MG NUMORPHAN ENDO | Opana (Oxymorphone Hydrochloride) Extended-Release Tablets, Endo Pharma, Approval | Opana (Oxymorphone Hydrochloride) Tablets, Endo Pharma, Approval | Opana ER (Oxymorphone Hydrochloride) Extended-Release Tablets, Endo Pharma, Labeling Revision | Opana (Oxymorphone Hydrochloride) Immediate-Release Tablets, Endo Pharma, Labeling Revision | OPANA (Oxymorphone Hydrochloride) Injection, Endo Pharma, Labeling Revision | Opana ER (Oxymorphone Hydrochloride) Extended-Release Tablets, Endo Pharma, Labeling Revision | OPANA ER (oxymorphone HCl) Extended-Release Tablets, Endo Pharma, Control Supplement | OPANA ER (oxymorphone hydrochloride) Extended-Release Tablets, Endo Pharma, Manufacturing Change or Addition | Oxymorphone Hydrochloride Extended-Release Tablets, Impax Laboratories, Inc., Tentative Approval | Oxymorphone Hydrochloride Extended-Release Tablets, Impax Laboratories, Inc., Approval | Oxymorphone Hydrochloride Tablets, Roxane Laboratories, Inc., Approval | Opana ER (oxymorphone hydrochloride) Tablets, Endo Pharmaceuticals, Inc., Labeling Revision | Oxymorphone Hydrochloride Extended-Release Tablets, Actavis South Atlantic LLC, Approval and Tentative Approval | Oxymorphone Hydrochloride Extended-Release Tablets, Impax Laboratories, Inc., Approval | Opana (oxymorphone hydrochloride) Tablets, Endo Pharmaceuticals, Inc., Labeling Revision | Oxymorphone Hydrochloride Tablets, Teva Pharmaceuticals, Approval | Opana (oxymorphone hydrochloride) Extended-Release Tablets, Endo Pharmaceuticals Inc., Approval
  
|